Novalee Texofab Profile
Key Indicators
- Authorised Capital ₹ 1.35 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.35 Cr
as on 17-11-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.35 Cr
as on 17-11-2024
- Revenue 718.75%
(FY 2023)
- Profit 197.13%
(FY 2023)
- Ebitda 793.00%
(FY 2023)
- Net Worth 107.00%
(FY 2023)
- Total Assets 16.24%
(FY 2023)
About Novalee Texofab
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.35 Cr and a paid-up capital of Rs 1.35 Cr.
The company currently has active open charges totaling ₹10.35 Cr.
Dilipbhai Patel, Mayurkumar Gohil, and Yash Makvana serve as directors at the Company.
- CIN/LLPIN
U17309GJ2020PTC116867
- Company No.
116867
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Novalee Texofab?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilipbhai Patel  | Director | 28-Sep-2020 | Current |
| Mayurkumar Gohil | Director | 28-Sep-2020 | Current |
| Yash Makvana | Director | 28-Sep-2020 | Current |
Financial Performance of Novalee Texofab.
Novalee Texofab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 718.75% increase. The company also saw a substantial improvement in profitability, with a 197.13% increase in profit. The company's net worth Soared by an impressive increase of 107%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novalee Texofab?
Unlock access to Novalee Texofab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Feb 2024 | ₹5.00 M | Open |
Others Creation Date: 23 Nov 2021 | ₹9.85 Cr | Open |
How Many Employees Work at Novalee Texofab?
Unlock and access historical data on people associated with Novalee Texofab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novalee Texofab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novalee Texofab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
